IL27 and graft versus host disease: Other studies have enhanced wild-type L. lactis to secrete IL-27 to treat immune colitis [24], and genetically modified Lactobacillus reuteri to secrete IL-22 for conditions such as IBD and Graft versus Host Disease (GvHD) [25].